Regulating haematopoietic stem cell dormancy and ageing through the netrin-1-neogenin axis
Regulating haematopoietic stem cell dormancy and ageing through the netrin-1-neogenin axis
Enasidenib plus azacitidine vs azacitidine monotherapy in mutant-IDH2 ND-AML
Investigating KRd versus KTd in NDMM patients with high-risk cytogenetics
AGMT_MM-1: Assessing the oral microbiome in patients with relapsed/refractory multiple myeloma
VIALE-A: Venetoclax with or without in treatment-naïve patients with acute myeloid leukaemia
OPTIC: A dose-ranging study of 3 starting doses of ponatinib for chronic-phase chronic myeloid leukaemia
CANDOR updated results: KdD versus Kd in patients with RRMM according to prior lines of therapy
CANDOR trial design: Investigating KdD versus Kd in relapsed/refractory multiple myeloma
GMMG-CONCEPT: Isa-KRd in front-line treatment of high-risk myeloma
Patient reported outcomes for the CANDOR trial for multiple myeloma
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer
CTC count as a prognostic marker for androgen deprivation plus orteronel or bicalutamide in mCSPC